Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00002793Phase 3Unknown
Phase 3, randomised, open-label trial of fluorouracil in colorectal cancer (CRC) (4 arms), sponsored by Universitätsklinikum Frankfurt. Primary endpoint: Treatment Efficacy. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00002793.